George H Conrades
CIK 1106231 · Executive Chairman · last filed 2025-06-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ORCL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
FIFTH FLOOR
CAMBRIDGE, MA 02139
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORCL | Director | 38,456 | $134.74 | $5.18M | -$19.61M | 29 | 2025-06-20 |
| Cyclerion Therapeutics, Inc. (CYCN) Delisted | Director | 31 | $23.52 | $729 | $0 | 6 | 2022-06-16 |
| AKAM | Director | 682,257 | $95.84 | $65.39M | $5.92M | 29 | 2018-05-22 |
| HOG | Director | 52,573 | $30.30 | $1.59M | -$2.75M | 13 | 2015-08-17 |
| IRWD | Director | 545,976 | $3.60 | $1.97M | $0 | 33 | 2015-06-05 |
| CAH | Director | 2,653 | $257.53 | $683.2K | $0 | 9 | 2008-11-19 |
Recent Filings · Page 5 of 13
124 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-04-29 | HOG | Grant (A) | — | $0 | EDGAR |
| 2015-04-15 | IRWD | Other (J) | −254,152 | $0 | EDGAR |
| 2015-02-24 | HOG | Sell (S) | −20,000 | -$1.25M | EDGAR |
| 2015-02-10 | HOG | Sell (S) | −19,700 | -$1.26M | EDGAR |
| 2014-12-01 | AKAM | Mixed | −33,000 | -$1.11M | EDGAR |
| 2014-03-18 | IRWD | Grant (A) | +195 | $0 | EDGAR |
| 2014-01-03 | IRWD | Grant (A) | +9,554 | $0 | EDGAR |
| 2013-12-23 | IRWD | Gift (G) | −240,000 | $0 | EDGAR |
| 2013-12-12 | AKAM | Buy (P) | +20,000 | $899.1K | EDGAR |
| 2013-11-08 | IRWD | Other (J) | +1,251 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.